Home › Asset managers › Compare 2024-2025 › BlackRock vs ProShares
BlackRock 2024-2025 · ProShares 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 8,258 | 7,560 | 520 | 178 | 93.6% | 92.8% |
| Board proposals | 7,109 | 6,611 | 367 | 131 | 94.7% | 94.1% |
| E&S shareholder proposals | 234 | 184 | 23 | 27 | 88.9% | 87.4% |
| Other items | 915 | 765 | 130 | 20 | 85.5% | 84.3% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
520 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | BlackRock | ProShares |
|---|---|---|---|---|---|---|
| AXOS FINANCIAL INC. | November 14, 2024 | To approve in a non-binding and advisory vote, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement. Say-on-Pay |
Board | For | FOR 30 funds |
AGAINST 15 funds |
| AXSOME THERAPEUTICS INC. | June 6, 2025 | Election of Director: Roger Jeffs, Ph.D. Director Elections |
Board | For | FOR 18 funds |
WITHHOLD 11 funds |
| AXSOME THERAPEUTICS INC. | June 6, 2025 | To approve the Company's 2025 Long-Term Incentive Plan. Compensation |
Board | For | FOR 18 funds |
AGAINST 11 funds |
| BANDWIDTH INC. | May 29, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 20 funds |
AGAINST 8 funds |
| BANK OF AMERICA CORP. | April 22, 2025 | Amending and restating the Bank of America Corporation Equity Plan Compensation |
Board | For | FOR 60 funds |
AGAINST 19 funds |
| BANK OF AMERICA CORP. | April 22, 2025 | Approving our executive compensation (an advisory, non-binding "Say on Pay" resolution) Say-on-Pay |
Board | For | FOR 77 funds |
AGAINST 19 funds |
| BEIGENE LTD | May 21, 2025 | THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 4 funds |
| BERRY GLOB | February 25, 2025 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Berry's named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement, which proposal is referred to as the "Berry Advisory Compensation Proposal." Say-on-Pay |
Board | Not determined | FOR 35 funds |
AGAINST 8 funds |
| BEYOND INC. | May 15, 2025 | The approval of an amendment and restatement of the Company's Amended and Restated 2005 Equity Incentive Plan (the "2005 Plan"). Compensation |
Board | For | FOR 6 funds |
AGAINST 10 funds |
| BGC GROUP INC. | September 16, 2024 | Approval, on an advisory basis, of executive compensation. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 12 funds |
| BIOCRYST PHARMACEUTICALS INC. | June 12, 2025 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. Compensation |
Board | For | FOR 19 funds |
AGAINST 11 funds |
| BLACKROCK FINANCE INC. | May 15, 2025 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. Say-on-Pay |
Board | For | FOR 53 funds |
AGAINST 7 funds |
| BLINK CHARGING CO. | July 16, 2024 | Approve, on a non-binding advisory basis, the compensation paid to our executive officers. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 7 funds |
| BOX INC. | July 2, 2024 | To approve our Amended and Restated 2015 Equity Incentive Plan. Compensation |
Board | For | FOR 25 funds |
AGAINST 16 funds |
| BOX INC. | June 27, 2025 | To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan to increase the number of shares reserved for issuance by 5,000,000 shares. Compensation |
Board | For | FOR 27 funds |
AGAINST 15 funds |
| BRANDYWINE REALTY TRUST | May 21, 2025 | Adoption of an amendment to the 2023 Long-Term Incentive Plan. Compensation |
Board | For | FOR 20 funds |
AGAINST 11 funds |
| BRIDGEBIO PHARMA INC. | June 20, 2025 | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 5,000,000 shares. Compensation |
Board | For | FOR 21 funds |
AGAINST 11 funds |
| BROOKLINE BANCORP INC. | May 21, 2025 | A proposal to approve, on a non-binding advisory basis, the compensation that may become payable to the named executive officers of Brookline in connection with the Mergers (the "Brookline Merger-Related Compensation Proposal"). Say-on-Pay |
Board | For | FOR 23 funds |
AGAINST 11 funds |
| BRUKER CORP. | May 29, 2025 | Approval of the adoption of the Bruker Corporation 2026 Incentive Compensation Plan. Compensation |
Board | For | FOR 31 funds |
AGAINST 10 funds |
| BUMBLE INC. | June 5, 2025 | Approval, on a non-binding advisory basis, of the compensation of the named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 24 funds |
AGAINST 8 funds |
| BURFORD CAPITAL LIMITED | May 14, 2025 | To re-elect John Sievwright as director. Director Elections |
Board | For | AGAINST 6 funds |
FOR 4 funds |
| C.H. ROBINSON WORLDWIDE INC. | May 8, 2025 | To approve the Amended and Restated 2022 Equity Incentive Plan. Compensation |
Board | For | FOR 44 funds |
AGAINST 19 funds |
| CABALETTA BIO INC. | June 9, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 8 funds |
| CACTUS INC. | May 13, 2025 | To approve the amendment of the Company's Long-Term Incentive Plan, as amended and restated effective May 16, 2023, to increase the number of shares of the Company's Class A common stock reserved for issuance under such plan from 5,500,000 to 8,500,000. Compensation |
Board | For | FOR 17 funds |
AGAINST 12 funds |
| CADIZ INC. | June 12, 2025 | Advisory vote on executive compensation as disclosed in the proxy materials. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 8 funds |
| CALIFORNIA WATER SERVICE GROUP | May 28, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 32 funds |
AGAINST 14 funds |
| CALIX INC. | May 8, 2025 | To approve 1,250,000 shares of common stock reserved for issuance for the matching component of the Calix, Inc. Stock Purchase and Matching Plan, which constitutes an amendment and restatement of the Third Amended and Restated 2017 Nonqualified Employee Stock Purchase Plan. Compensation |
Board | For | FOR 23 funds |
AGAINST 13 funds |
| CALIX INC. | May 8, 2025 | To approve the Calix, Inc. Fourth Amended and Restated 2019 Equity Incentive Award Plan. Compensation |
Board | For | FOR 23 funds |
AGAINST 13 funds |
| CALIX INC. | May 8, 2025 | To approve, on a non-binding, advisory basis, Calix's named executive officer compensation. Say-on-Pay |
Board | For | FOR 36 funds |
AGAINST 13 funds |
| CANOO INC. | December 6, 2024 | To approve an amendment to our 2020 Employee Stock Purchase Plan (the "ESPP") to increase the number of shares of our Common Stock available and reserved for issuance under the ESPP by an additional 1,000,000 shares of Common Stock. Compensation |
Board | For | AGAINST 4 funds |
FOR 4 funds |
| CARDLYTICS INC. | May 20, 2025 | Approval of the Cardlytics, Inc. 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| CAREDX INC. | June 12, 2025 | Approval of an amendment to 2024 Equity Incentive Plan. Compensation |
Board | For | FOR 17 funds |
AGAINST 10 funds |
| CARETRUST REIT INC. | April 29, 2025 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 40 funds |
AGAINST 14 funds |
| CENTESSA PHARMACEUTICALS PLC | June 20, 2025 | To generally and unconditionally authorise the directors of the Company or any duly authorised committee of the directors, in accordance with section 551 of the UK Companies Act 2006 (the "Companies Act"), to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of pounds133,184. Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CENTURY ALUMINUM CO. | June 16, 2025 | Proposal to approve, on an advisory basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 29 funds |
AGAINST 11 funds |
| CERVOMED INC. | June 23, 2025 | To approve the CervoMed Inc. 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| CEVA INC. | May 5, 2025 | To approve an amendment and restatement of the Company's 2011 Equity Incentive Plan. Compensation |
Board | For | FOR 14 funds |
AGAINST 14 funds |
| CHEGG INC. | June 4, 2025 | To approve the Chegg, Inc. Amendment to the 2023 Equity Incentive Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| CHEMUNG FINANCIAL CORP. | June 3, 2025 | To approve the Chemung Financial Corporation 2025 Equity Incentive Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| CHEWY | July 11, 2024 | To approve the Chewy, Inc. 2024 Omnibus Incentive Plan, including an increase in the number of shares reserved for issuance by 80,000,000 shares. Compensation |
Board | For | FOR 10 funds |
AGAINST 3 funds |
| CHUBB LIMITED | May 15, 2025 | Election of Evan G. Greenberg as Chairman of the Board of Directors Corporate Governance |
Board | For | FOR 34 funds |
AGAINST 16 funds |
| CIBUS INC | May 22, 2025 | Ratification of the appointment of BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | FOR 4 funds |
AGAINST 4 funds |
| CIMPRESS PLC | November 20, 2024 | Amend Cimpress' 2020 Equity Incentive Plan to increase the number of ordinary shares issuable under the plan. Compensation |
Board | For | FOR 13 funds |
AGAINST 8 funds |
| CIMPRESS PLC | November 20, 2024 | Reappoint Dessislava Temperley to Cimpress' Board of Directors to serve for a term of three years. Director Elections |
Board | For | FOR 13 funds |
AGAINST 8 funds |
| CINTAS CORP. | October 29, 2024 | To approve the Cintas Corporation 2016 Amended and Restated Equity and Incentive Compensation Plan. Compensation |
Board | For | FOR 52 funds |
AGAINST 26 funds |
| CITI TRENDS INC. | June 5, 2025 | Vote to approve an Amendment to the 2021 Incentive Plan to increase the number of shares available by 500,000 for grant. Compensation |
Board | For | FOR 5 funds |
AGAINST 8 funds |
| CITIGROUP INC. | April 29, 2025 | Approval of additional shares for the Citigroup 2019 Stock Incentive Plan. Compensation |
Board | For | FOR 62 funds |
AGAINST 17 funds |
| CITIZENS & NORTHERN CORP. | April 24, 2025 | TO APPROVE, IN AN ADVISORY (NON-BINDING) VOTE, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 8 funds |
| CITIZENS FINANCIAL GROUP INC. | April 24, 2025 | Advisory Vote on Executive Compensation. Say-on-Pay |
Board | For | FOR 64 funds |
AGAINST 18 funds |
| CLARUS CORP. | May 29, 2025 | To consider and vote on a proposal to amend and restate the Company's 2015 Stock Incentive Plan to, among other things, extend the term of such plan by 10 years and reserve 7,500,000 shares of the Company's common stock for issuance under such plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 8 funds |
| COASTAL FINANCIAL CORP. | May 28, 2025 | To approve the Second Amendment to the Coastal Financial Corporation 2018 Omnibus Incentive Plan (the "2018 Plan"), including an increase in the number of authorized shares under the 2018 Plan. Compensation |
Board | For | FOR 14 funds |
AGAINST 8 funds |
| CODEXIS INC. | June 10, 2025 | To approve an amendment to the Codexis, Inc. 2019 Incentive Award Plan to increase the number of shares available for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 11 funds |
AGAINST 9 funds |
| CODEXIS INC. | June 10, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 18 funds |
AGAINST 9 funds |
| COHERUS BIOSCIENCES INC. | June 11, 2025 | To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote). Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 8 funds |
| COINBASE GLOBAL INC. | June 18, 2025 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 56 funds |
AGAINST 1 fund |
| COLLEGIUM PHARMACEUTICAL INC. | May 15, 2025 | To approve the Collegium Pharmaceutical, Inc. 2025 Equity Incentive Plan Compensation |
Board | For | FOR 17 funds |
AGAINST 14 funds |
| COMPOSECURE INC. | May 28, 2025 | A proposal to approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation to increase the authorized number of shares of the Company's Common Stock from 250,000,000 shares to 1,000,000,000 shares. Capital Structure |
Board | For | FOR 12 funds |
AGAINST 8 funds |
| CONCENTRA GROUP HOLDINGS PARENT INC | May 1, 2025 | Hold a non-binding advisory vote on the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 5 funds |
| CONTANGO ORE INC. | June 10, 2025 | To conduct a non-binding, advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 8 funds |
| COOPER-STANDARD HOLDINGS INC. | May 15, 2025 | Advisory Vote on Named Executive Officer Compensation. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 8 funds |
| CUTERA INC. | July 15, 2024 | Approval of the amendment and restatement of our 2019 Equity Incentive Plan to increase the total shares available for issuance under the 2019 Equity Incentive Plan by 2,395,275 shares. Compensation |
Board | For | FOR 7 funds |
AGAINST 7 funds |
| CVR ENERGY INC. | June 5, 2025 | To approve the Third Amended & Restated CVR Energy, Inc. 2007 Long-Term Incentive Plan. Compensation |
Board | For | FOR 18 funds |
AGAINST 11 funds |
| CVR ENERGY INC. | June 5, 2025 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | FOR 29 funds |
AGAINST 11 funds |
| CVS HEALTH CORP. | May 15, 2025 | Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. Shareholder Rights and Defenses |
Board | For | FOR 44 funds |
AGAINST 17 funds |
| DAVE & BUSTER'S ENTERTAINMENT INC. | June 18, 2025 | Approval of 2025 Omnibus Incentive Plan Compensation |
Board | For | FOR 14 funds |
AGAINST 11 funds |
| DEVON ENERGY CORP. | June 4, 2025 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | FOR 54 funds |
AGAINST 16 funds |
| DIGI INTERNATIONAL INC. | February 3, 2025 | Company proposal to approve the amendment and restatement of the Digi International Inc. 2021 Omnibus Incentive Plan. Compensation |
Board | For | FOR 15 funds |
AGAINST 11 funds |
| DIGITALBRIDGE GROUP INC. | May 23, 2025 | To approve, on a non-binding, advisory basis, named executive officer compensation. Say-on-Pay |
Board | For | FOR 21 funds |
AGAINST 8 funds |
| DIGITALOCEAN HOLDINGS INC. | June 9, 2025 | Election of Class I Director: Padmanabhan Srinivasan Director Elections |
Board | For | FOR 17 funds |
WITHHOLD 12 funds |
| DOCUSIGN INC. | May 29, 2025 | Approval, on an advisory basis, of our named executive officers' compensation Say-on-Pay |
Board | For | FOR 55 funds |
AGAINST 11 funds |
| DOMO INC. | June 24, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 15 funds |
AGAINST 8 funds |
| EASTERN CO. | April 30, 2025 | Nonbinding advisory vote to approve the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 8 funds |
| EDITAS MEDICINE INC. | May 29, 2025 | To approve an amendment and restatement of the Company's 2015 Stock Incentive Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 9 funds |
| ENANTA PHARMACEUTICALS INC. | March 13, 2025 | To approve an amendment to our 2019 Equity Incentive Plan. Compensation |
Board | For | FOR 10 funds |
AGAINST 9 funds |
| ENOVIX CORP. | June 12, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 19 funds |
AGAINST 8 funds |
| ENPHASE ENERGY INC. | May 14, 2025 | To approve an amendment and restatement of our 2021 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 4,000,000 shares. Compensation |
Board | For | FOR 29 funds |
AGAINST 19 funds |
| ENTEGRIS INC. | April 23, 2025 | Approval, by non-binding vote, of the compensation paid to Entegris, Inc.'s named executive officers (advisory vote). Say-on-Pay |
Board | For | FOR 53 funds |
AGAINST 13 funds |
| ENTERPRISE BANCORP INC. | April 3, 2025 | To approve, on a non-binding, advisory basis, the compensation payable to the named executive officers of Enterprise in connection with the merger (the "Enterprise compensation proposal"). Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 8 funds |
| EOS ENERGY ENTERPRISES INC | May 15, 2025 | Amendment to our Amended and Restated 2020 Equity Compensation Plan. Compensation |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| EQUINIX INC. | May 21, 2025 | Approval of an amendment to the Equinix, Inc. 2020 Equity Incentive Plan to increase the number of plan shares reserved for issuance by 3.3 million shares Corporate Governance |
Board | For | FOR 59 funds |
AGAINST 19 funds |
| ESAB CORP. | May 8, 2025 | To approve the Amended and Restated ESAB Corporation 2022 Omnibus Incentive Plan. Compensation |
Board | For | FOR 19 funds |
AGAINST 7 funds |
| ESSENTIAL UTILITIES INC. | May 7, 2025 | To approve an advisory vote on the compensation paid to the Company's named executive officers for 2024. Say-on-Pay |
Board | For | FOR 52 funds |
AGAINST 9 funds |
| EVERSOURCE ENERGY | May 1, 2025 | Consider an advisory proposal approving the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | FOR 59 funds |
AGAINST 18 funds |
| EVGO INC. | May 15, 2025 | To approve the amendment of our 2021 Long Term Incentive Plan. Compensation |
Board | For | FOR 11 funds |
AGAINST 8 funds |
| EXPEDIA GROUP INC. | June 3, 2025 | Approval, on an advisory basis, of the compensation of Expedia Group's named executive officers. Say-on-Pay |
Board | For | FOR 51 funds |
AGAINST 16 funds |
| EYEPOINT PHARMACEUTICALS INC. | June 18, 2025 | To approve Amendment No. 2 to the EyePoint Pharmaceuticals, Inc. 2023 Long-Term Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 2,900,000 shares. Compensation |
Board | For | FOR 15 funds |
AGAINST 11 funds |
| FARO TECHNOLOGIES INC. | May 21, 2025 | Amendment to the FARO Technologies, Inc. 2022 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 1,500,000. Compensation |
Board | For | FOR 8 funds |
AGAINST 9 funds |
| FASTLY INC. | June 11, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 9 funds |
| FATE THERAPEUTICS INC. | May 29, 2025 | To approve the amendment and restatement of the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. Compensation |
Board | For | FOR 9 funds |
AGAINST 9 funds |
| FIDELITY NATIONAL FINANCIAL INC. | June 11, 2025 | Approval of the redomestication of the Company from the State of Delaware to the State of Nevada by conversion. Extraordinary Transactions |
Board | For | FOR 40 funds |
AGAINST 7 funds |
| FIRST BANCSHARES INC. | October 22, 2024 | A proposal to approve, on an advisory (non-binding) basis, specified compensation that may become payable to the named executive officers of The First Bancshares, Inc. in connection with the merger. Say-on-Pay |
Board | For | FOR 19 funds |
AGAINST 8 funds |
| FIRST FOUNDATION INC. | May 29, 2025 | To approve the First Foundation Inc. Amended and Restated 2024 Equity Incentive Plan. Compensation |
Board | For | FOR 9 funds |
AGAINST 8 funds |
| FIRST WESTERN FINANCIAL INC. | June 4, 2025 | To approve the First Western Financial, Inc. Omnibus Incentive Plan, as amended and restated April 23, 2025. Compensation |
Board | For | FOR 7 funds |
AGAINST 8 funds |
| FLAGSTAR FINANCIAL INC. | June 4, 2025 | An advisory vote to approve, on a non-binding basis, compensation of our named executive officers disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | FOR 39 funds |
AGAINST 17 funds |
| FLEX LNG LTD | May 8, 2025 | ELECT MIKKEL STORM WEUM AS NEW DIRECTOR Director Elections |
Board | For | FOR 5 funds |
AGAINST 8 funds |
| FMC CORP. | April 29, 2025 | Approval, by non-binding vote, of executive compensation. Say-on-Pay |
Board | For | FOR 49 funds |
AGAINST 18 funds |
| FORTIVE CORP. | June 3, 2025 | To approve the amendment and restatement of the 2016 Stock Incentive Plan to extend the term of the plan. Compensation |
Board | For | FOR 44 funds |
AGAINST 17 funds |
| FOX FACTORY HOLDING CORP. | May 9, 2025 | To approve, on an advisory basis, the resolution approving the compensation of Fox Factory Holding Corp.'s named executive officers. Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 11 funds |
| FRANKLIN BSP REALTY TRUST INC. | May 28, 2025 | ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 11 funds |
| FRONTIER COMMUNICATIONS PARENT INC. | November 13, 2024 | To adopt the Agreement and Plan of Merger, dated as of September 4, 2024 (the "merger agreement"), by and among Frontier Communications Parent, Inc. (the "Company"), Verizon Communications Inc. ("Verizon") and France Merger Sub Inc. ("Merger Sub"), pursuant to which Merger Sub will be merged with and into the Company (the "merger"), with the Company surviving the merger as a wholly owned subsidiary of Verizon. Extraordinary Transactions |
Board | For | FOR 22 funds |
ABSTAIN 7 funds |
← Previous Page 3 of 6 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.